A Multicenter Phase 2 study of Hypofractionated Stereostatic Boost in Intermediate Risk Prostate Carcinoma: A 5-Year Analysis of the CKNO-PRO Trial
- 8 October 2019
- journal article
- research article
- Published by Elsevier BV in Endocrine
- Vol. 106 (1), 116-123
- https://doi.org/10.1016/j.ijrobp.2019.09.039
Abstract
No abstract availableFunding Information
- Institut National Du Cancer (PHRC-K 2009)
This publication has 19 references indexed in Scilit:
- Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate CancerJournal of Clinical Oncology, 2016
- Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialThe Lancet Oncology, 2016
- Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data BaseJournal of Urology, 2015
- A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation TherapyEuropean Urology, 2013
- Health-Related Quality of Life After Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Results From a Multi-institutional Consortium of Prospective TrialsEndocrine, 2013
- Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trialsRadiotherapy and Oncology, 2013
- Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancerRadiotherapy and Oncology, 2012
- Randomized Trial Comparing Iridium Implant Plus External-Beam Radiation Therapy With External-Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the ProstateJournal of Clinical Oncology, 2005
- Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunctionInternational Journal of Impotence Research, 1999
- One-Sample Multiple Testing Procedure for Phase II Clinical TrialsBiometrics, 1982